Jason Paul Steik insider trades

Open-market stock purchases and sales by Jason Paul Steik, Chief Clinical Officer at Pennant Group, Inc, from SEC Form 4 filings since Mar 5, 2026.

Recent trades

DateStockTradeValue
Aug 6, 2026PNTG Pennant Group, IncSold$53.7K
Mar 5, 2026PNTG Pennant Group, IncBought (not open market)$866K

Companies traded

  • PNTG Pennant Group, Inc: 1 sale, last Aug 6, 2026

Get free alerts when Jason Paul Steik files a new trade →